What is CrossLink Life Sciences?
Founded in 1978 and headquartered in Norcross, Georgia, CrossLink Life Sciences operates as a key distributor of Orthopaedic and Spine implants across the United States. The organization serves as a vital link between medical device manufacturers and a broad network of surgeons and healthcare institutions, facilitating access to critical surgical technologies.
How much funding has CrossLink Life Sciences raised?
CrossLink Life Sciences has raised a total of $5M across 1 funding round:
Debt
$5M
Debt (2020): $5M with participation from PPP
Key Investors in CrossLink Life Sciences
PPP
Public-Private Partnership
What's next for CrossLink Life Sciences?
The recent major strategic investment signals a period of potential expansion and enhanced operational capabilities for CrossLink Life Sciences. This capital infusion is likely to bolster its distribution network, potentially enabling the company to broaden its product offerings or deepen its relationships with surgical professionals. As an established entity in the medical device sector, this strategic financing positions CrossLink Life Sciences for continued growth and influence within the orthopaedic and spine implant market.
See full CrossLink Life Sciences company page
